Brentuximab vedotin plus ICE as a second line treatment in R/R Hodgkin lymphoma
Ryan Lynch • 10 Dec 2020
Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.
Keep up to date with all the latest news with our monthly newsletter